Cynata Therapeutics Receives Notice of Allowance from EPO for Patent Application

Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited announced today that a Notice of Allowance has been received from the European Patent Office (EPO) for a patent application covering its proprietary Cymerus™ mesenchymal stem cell technology. The patent … Continue reading Cynata Therapeutics Receives Notice of Allowance from EPO for Patent Application

Sirtex Medical Provides Update on Scheme of Arrangement FIRB Approval

Sirtex Medical Limited (ASX:SRX)  announced the Australian Foreign Investment Review Board (FIRB) has decided that the Commonwealth of Australia has no objection to Varian Medical Systems, Inc. (Varian) either directly or through one or more interposed wholly-owned subsidiaries acquiring up … Continue reading Sirtex Medical Provides Update on Scheme of Arrangement FIRB Approval

Sticky post

Cann Group Announces Receipt of Import Permits for Genetics and Cannabis Oil

Cann Group Limited (ASX: CAN) has been granted import permits by the drug control section of the Therapeutic Goods Administration (TGA) that enables the company to commence the import of genetics and cannabis oils from its Canadian partners. The receipt … Continue reading Cann Group Announces Receipt of Import Permits for Genetics and Cannabis Oil